Sean M. McBride
Papers
2
Total Citations
100
H-Index
2
About
Sean M. McBride is a leading radiation oncologist whose research focuses on treatment deintensification for HPV-associated oropharyngeal cancer (OPC) and the application of advanced radiosurgery techniques. His most cited work, a 2022 consensus paper (57 citations), addresses the critical challenge of reducing long-term toxicities from chemoradiation in HPV-positive OPC patients, who have a favorable prognosis. By synthesizing expert perspectives on controversies and future directions, McBride has helped shape clinical guidelines that aim to preserve quality of life without compromising oncologic outcomes. Earlier, his Phase 1 dose-escalation study of robotic radiosurgery for inoperable primary renal cell carcinoma (43 citations) demonstrated the feasibility and safety of non-invasive ablation, expanding treatment options for patients who are poor surgical candidates. McBride’s contributions bridge the gap between innovative technology and patient-centered care, offering evidence that supports safer, more tailored therapies. His work is widely cited by clinicians and researchers seeking to minimize treatment burden while maintaining efficacy, particularly in head and neck and genitourinary cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2